Skip to main content

Table 1 Demographic characteristics of subjects in the study

From: Comparison of the euploidy rate in preimplantation genetic testing for aneuploidy cycles following progestin-primed versus gonadotropin-releasing hormone antagonist protocol: a randomized controlled study

Variables

PPOS group (n = 120)

Antagonist group (n = 120)

P-value

Age of women (years)

39.0 (35.3–41.0)

39.0 (34.0–42.0)

0.894

Age of husbands (years)

39.0 (34.3–43.0)

39.0 (34.0–43.0)

0.564

Body mass index of women (kg/m²)

22.1 (20.5–23.6)

21.6 (20.0-23.6)

0.649

Primary infertility (%)

21.7 (26/120)

32.5 (39/120)

0.059

Infertility duration (years)

3.0 (1.0–5.0)

3.0 (1.5-5.0)

0.571

Serum AMH level (ng/ml)

2.2 (1.0-4.2)

1.9 (1.1–3.9)

0.637

Basal FSH level (IU/L)

7.1 (6.0-8.6)

7.2 (6.0-8.9)

0.887

Basal estradiol level (pg/ml)

42.7 (33.0-51.5)

37.8 (32.0-50.2)

0.245

Basal LH level (IU/L)

3.6 (2.6-5.0)

3.8 (2.8–4.8)

0.709

Basal progesterone level (ng/L)

0.6 (0.5–0.8)

0.6 (0.5–0.7)

0.517

Basal antral follicle count

10.0 (6.0–15.0)

9.0 (5.0–15.0)

0.157

Indication of PGT-A(%)

  

0.286

Advanced maternal age

45.0 (54/120)

45.8 (55/120)

 

Recurrent pregnancy loss

18.3 (22/120)

16.7 (20/120)

 

Repeated implantation failure

14.2 (17/120)

20.0 (24/120)

 

Mixed

22.5 (27/120)

17.5 (21/120)

Â